INSIGHTS ON PHARMACEUTICAL PACKAGING
-
![Medical Vials-GettyImages-547146854]( "Microbial Challenge In-Use Studies")
Microbial Challenge In-Use StudiesLearn more about how a partner with expertise can help you navigate the complex landscape of microbial challenge in-use studies and ensure the highest standards of patient care.
-
![iStock-1313401849-syringe]( "Overcome Common Pre-Filled Syringe Challenges Through Partnership")
Overcome Common Pre-Filled Syringe Challenges Through PartnershipThe pre-filled syringe space is one of the fastest growing pharma sectors, offering greater patient safety and lower manufacturing costs. But pre-filled doesn’t translate to easily filled; there are particular obstacles to overcome.
-
![West-MDO 1 - GC_APP_Assembled and Unassembled Vials V1]( "FAQs On The Revised EU GMP Annex 1: Volume 1")
FAQs On The Revised EU GMP Annex 1: Volume 1The revised GMP Annex 1 guidelines emphasize quality risk management, enhanced environmental monitoring, and data integrity, which aim to minimize contamination and ensure patient safety.
-
![OP 1 - GCAPP_20mm Seal-Stopper_Vial Size 10_Valor-V2 (2) - Copy]( "Improve Speed To Market By Mitigating Vial And Stopper Incompatibility")
Improve Speed To Market By Mitigating Vial And Stopper IncompatibilityThese studies indicate that with a properly assembled vial containment system, good CCI performance can be achieved with stoppers of a given elastomer, independent of configuration/size, or vial style.
-
Bridging The Gap Between Product Readiness And Equipment Availability12/15/2025
Discover how manual precision at scale bridges packaging gaps, accelerates product launches, and ensures uninterrupted supply to deliver quality when automated equipment isn’t yet operational.
-
Key Considerations When Choosing A Device For Dry Powder Nasal Delivery10/21/2024
Building on previous discussions, here we discuss the benefits of nasal delivery and the challenges of developing dry powder formulations by focusing on key devices that can be used for delivering dry powder nasal dosage forms.
-
Meeting Annex 1: A Proactive Approach To Regulatory Compliance3/4/2025
It was imperative for a large European CMO producing multiple biologics to select the right product quality and value for each customer to comply with the August 2023 EU GMP Annex 1 revision.
-
Future Of Pharma Packaging: Trends, Tech, And Patient Solutions9/25/2025
Explore how traditional and innovative pharmaceutical packaging formats improve patient adherence, support emerging therapies, and shape the future of drug delivery and treatment outcomes.
-
Sachet Packaging Solutions3/4/2025
Discover versatile, high-quality sachets for manufacturers and consumers with an ideal fill weight of 2 grams and above that is suitable for food or liquid formulas.
PHARMACEUTICAL PACKAGING SOLUTIONS
-
![HERMA - 362C]( "Two-Sided Pharmaceutical Labeler: HERMA 362C")
The HERMA 362C is a compact and flexible two-sided labeling machine designed for quick and easy changeovers. It operates largely without format parts, accommodating a wide range of product formats.
-
The Thermo Scientific™ Sentinel™ Multiscan Metal Detector utilizes an innovative new technology to overcome the limitation of fixed single or dual frequency metal detectors that can miss metal contaminants hidden in product signals.
-
![NeoTOP x]( "Toploading Pharmaceutical Packaging Cartoner With Partition: Dividella NeoTOP x")
At Körber, we package pharmaceutical products more than safely: beyond that, our packaging solutions are sustainable, environmentally conscious, and patient-friendly.
-
![Blow Fill Seal Packaging]( "Blow-Fill-Seal Packaging Systems For Large Volume Nebulizers And Humidifiers")
Large volume humidifiers and nebulizers – typically in sizes from 250 – 1000mL – can be specifically designed to fit existing delivery devices. Custom designs to facilitate the control of humidification in oxygen delivery can be developed.
-
![Pharmaceutical Container Closure Integrity Testing For IV Bags]( "Pharmaceutical Container Closure Integrity Testing For IV Bags")
The Food and Drug Administration (FDA), United States Pharmacopeia (USP) and EMA Annex 1 issue strict guidelines for testing the integrity of IV bags and containers closed by fusion. IV bag manufacturers are one among many sterile product manufacturers that must meet these test requirements for container closure integrity.
